Due to the situation with the corona pandemic, XVIVO Perfusion's Nomination Committee, and the shareholders who have appointed the members in the Nomination Committee, has decided to withdraw the proposal that XVIVO Perfusion's Annual General Meeting on March 31, 2020 approves an increase in Board remuneration (item 12 on the agenda). Instead, the Nomination Committee, and the shareholders who have appointed the members in the Nomination Committee, proposes unchanged Board remuneration compared to 2019. The Nomination Committee's other proposals for the Annual General Meeting remain unchanged.